Organization | Palo Alto Medical Foundation

Palo Alto Medical Foundation Report issue

Foundation Phase 1 Phase 3 Phase 4

Founded: Palo Alto CA United States (1930)

Organization Overview

First Clinical Trial

1999

NCT00002064

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2014

Timeline

NOW

Now

Alternative names

Palo Alto Medical Foundation

Active Ingredients

Drugs in Phase 4 Trials (1)

smallpox vaccine, live attenuated (imvamune) (1 trial)

Drugs in Phase 3 Trials (2)

niacin (2 trials)

prednisone (meticorten) (1 trial)

Drugs in Phase 1 Trials (6)

docetaxel (taxotere) (1 trial)

fluorouracil (efudex) (1 trial)

gemcitabine (gemzar) (1 trial)

leucovorin (1 trial)

ubidecarenone (1 trial)

ubiquinone (1 trial)

Drugs in Other Trials (3)

clindamycin (cleocin) (1 trial)

domperidone (1 trial)

pyrimethamine (daraprim) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Neoplasm Metastasis (Phase 1)

Retinal Vein Occlusion (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 12